최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of Korean Medicine = 대한한의학회지, v.38 no.1, 2017년, pp.34 - 45
조영권 (대전대학교 한의과대학 경락경혈학교실) , 이찬 (대전대학교 한의과대학 경락경혈학교실) , 이현진 (대전대학교 한의과대학 경락경혈학교실) , 임윤경 (대전대학교 한의과대학 경락경혈학교실)
Objectives: This study aimed to investigate the effect of banhasasim-tang intravenous herbal acupuncture (BST-IVHA) on emesis induced by chemotherapy in rats. Methods: This study used methotrexate(MTX)-induced Rat-Pica model. The rats were randomly allocated into seven groups; normal group, two sali...
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
Methotrexate은 어떻게 사용되고 있는가? | 현재 항암화학요법 약물로 사용되고 있는 Methotrexate(MTX)는 엽산의 길항제로 항암 효과를 나타내서 항종양제로 사용되고 있는데 특히 융모상피암에 많이 이용되고 또한 면역 억제 효과도 나타내므로 류마티스 관절염과 같은 자가면역질환에도 널리 사용되고 있다6). 하지만 골수기능 억제 및 점막염, 신부전, 간염, 폐섬유화, 중추신경계 독성 및 오심, 구토 등의 소화기계 장애 등의 부작용을 나타낸다7). | |
항암화학요법이란? | 항암화학요법은 암세포의 대사 과정에서 여러 가지 경로를 통하여 개입하거나 암세포의 DNA에 직접 작용함으로써 암세포에 대한 세포독성을 유발시켜 암세포를 파괴하는 치료 방식이다1). 항암화학요법은 암치료에 있어 가장 먼저 고려되는 치료법이 되는 경우도 많으며, 수술이나 방사선 치료 전후의 보조 요법으로 선택되어, 암환자의 60~75% 정도가 화학요법을 받고 있다2). | |
항암제의 부작용중 흔히 발생되면서도 고통이 따르는 힘든 부작용에는 어떤것이 있는가? | 위장관을 구성하고 있는 식도, 구강, 점막 외에도 몸 전체의 세포에 손상을 미치며, 여러 가지 치명적인 부작용을 유발하기도 한다3). 이러한 여러 부작용 중 오심과 구토는 항암화학요법과 관련하여 흔히 발생되면서도 고통이 따르는 힘든 부작용이다4). 항암화학요법으로 인하여 발생하는 구토는 여러 가지 요인들에 의해 영향을 받아 발생하므로 예후를 판단하기 어렵게 만들 뿐 아니라, 결과적으로 암으로부터의 회복을 지연시키고, 항암치료 자체를 중단하게 만드는 요인이 되기도 한다5). |
Park JG, Park CI, Kim NK. Oncology. 1st ed. Seoul:Ilchokak. 2009:3, 128.
Graham KM, Pecoraro DA, Ventura M, Meyer CC. Reducing the incidence of stomatitis using a quality assessment and improvement approach. Cancer Nurs. 1993;16(2:117-22.
Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, et al. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer. 2004;100(9): 1995-2025.
Hockenberry-eaton M, Benner A. Patterns of nausea and vomiting in children: nursing assessment and intervention. Oncol Nurs Forum. 1990;17(4):575-84.
Kim HJ, Kim HS. Nausea/Vomiting and Self -care in patients with Cancer on Chemotherapy. J Korean Acad Funda Nurs. 2005;12(2:180-5.
Ackland SP, Schilsky RL. High-dose methotrexate: a critical reappraisal. J Clin Oncol. 1987;5(12): 2017-31.
Jacobs SA, Stoller RG, Chabner BA, Jones DG. 7-Hydroxy methotrexate as a urinary metabolite in human subjects and rhesus monkeys receiving high-dose methotrexate. J Clin Incest. 1976;57(2):534-8.
Kim SH, Kim DH. Traditional oriental medicine's therapy on anticancer agent's side effect. Daejeon University Journal of the institute of Oriental Medicine. 1993;2(1):32-51.
Bae BC. PyoJunImSangBangJeHak(Clinical Basic of Herb Prescription). Seoul:SeongBoSa. 1995: 123-5.
Meridians & Acupoints Compliation Committe of Korean Medical Colleges. Principles of Meridians & Acupoints; A Guidebook for College Students. 7th ed. Daejeon:JongRyeoNaMu Publishing. 2015;101, 106.
Yamamoto K, Takeda N, Yamatodani A. Establishment of an Animal Model for Radiation-induced Vomiting in Rats Using Pica. J Radiat Res. 2002;43(2):135-41.
Lohr L. Chemotherapy-induced nausea and vomiting. Cancer J. 2008;14(2):85-93.
Kim W. Chemotherapy-induced nausea and vomiting. KSCO News&Education. 2008;4:24-9.
de Boer-Dennert M, de Wit R, Schmitz PI, Djontono J, v Beurden V, Stoter G, et al. Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists. Br J Cancer. 1997;76(8):1055-61.
Kim SG. Managements of Chemotherpay Induced Nausea and Vomiting. Korean J Clin Oncol. 2012;8(1):23-9.
Hornby PJ. Central neurocircuitry associated with emesis. Am J Med. 2001;111(Suppl 8A): 106S-12S.
Kris MG, Radford JE, Pizzo BA, Inabinet R, Hesketh A, Hesketh PJ. Use of an NK1 receptor antagonist to prevent delayed emesis after cisplatin. J Natl Cancer Inst. 1997;89(11): 817-8.
Jordan K, Gralla R, Jahn F, Molassiotis A. International antiemetic guidelines on chemotherapy induced nausea and vomiting (CINV): Content and implementation in daily routine practice. Eur J Pharmacol. 2014;722:197-202.
Schwartzberg L. Chemotherapy-induced nausea and vomiting: state of the art in 2006. J Support Oncol. 2006;4(2 Suppl 1):3-8.
Takahashi T, Hoshi E, Takagi M, Katsumata N, Kawahara M, Eguchi K. Multicenter, phase II, placebo controlled, double-blind, randomized study of aprepitant in Japanese patients receiving high-dose cisplatin. Cancer Sci. 2010;101(11):2455-61.
Botrel TE, Clark OA, Clark L, Paladini L, Faleiros E, Pegoretti B. Efficacy of palonosetron (PAL) compared to other serotonin inhibitors (5-HT(3)R) in preventing chemotherapy induced nausea and vomiting (CINV) in patients receiving moderately or highly emetogenic (MoHE) treatment: systematic review and meta-analysis. Support Care Cancer. 2010; 19(6):823-32.
Saito M, Aogi K, Sekine I, Yoshizawa H, Yanagita Y, Sakai H, et al. Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial. Lancet Oncol. 2009;10(2):115-24.
Shin HS, Lee SB, Ryu KH. Effect of Nei-Guan Acupressure on Nausea, Vomiting and Anorexia in Gynecological Cancer Patients Receiving Chemotherapy. J. East-West Nurs. Res. 2009;15(1):26-33.
Park YK, Park KI, Park KS, Hwang DS, Lee CH, Jang JB, et al. A Clinical Study on Two Cases of Chemotherapy Induced Nausea and Vomiting (CINV) and Radiotherapy Induced Nausea and Vomiting (RINV) Patients Treated by Gamihachul-Tang-Gagam-bang. The Journal of Oriental Obstetrics & Gynecology. 2015; 28(3):97-106.
Raghavendran HR, Rekha S, Shin JW, Kim HG, Wang JH, Park HJ, et al. Effects of Korean ginseng root extract on cisplatin-induced emesis in a rat-pica model. Food and Chemical Toxicology. 2011;49(1): 215-221.
Garcia MK, McQuade J, Haddad R, Patel S, Lee R, Yang PY, et al. Systematic Review of Acupuncture in Cancer Care: A Synthesis of the Evidence. JCO. 2013;31(7):952-60.
Cheon SY, Zhang XY, Lee IS, Cho SH, Chae YB, Lee HS. Pharmacopuncture for cancer care: a systematic review. Evidence-Based Complementary and Alternative Medicine. 2014;2014:804746.
Internal Medicine Professors of Korean Medical Colleges. Digestive system in Internal Medicine. Seoul:HanSeong Planning. 2000:84-8.
Mun JJ, Ahn KS, Kim SH, Uhm HS, Ji GY, Kim SB. SangHanRonJeongHae(Interpretation of Treatise on Febrile Diseases). Seoul:Han UiMunHwaSa. 2003:317-20.
Lee JS, Kim JS, Ryu BH, Yun SH. Effect of Banhasasimtang Granule on Gastric Emptying in Rats. Korean J. Orient. Int. Med. 2006;27(2): 471-9
Ryu BH, Ryu KW, Kim JS, Yun SH. Evaluation for Therapeutic Effectiveness of Banwhasashim-tang in Functional Dyspepsia. Korean J. Orient. Int. Med. 2003;24(2):329-36
Jang MU, Im SU. Experimental Study for Effect of Banhasasim-tang on Mice with Reflux Esophagitis. Korean J. Orient. Int. Med. 2013;34(4):362-74.
Lee JH. DongUiImSangNaeGwaHak I(Clinical Internal Medicine of Oriental Medicine I). Seoul:BubIn Books. 1999:271-8.
Takeda N, Hasegawa S, Morita M, Matsunaga T. Pica in rats is analogous to emesis: an animal model in emesis research. Pharmacol. Biochem. Behav. 1993;45(4):817-21.
Raghavendran HR, Rekha S, Cho HK, Jang SS, Son CG. Ginsenoside rich fraction of Panax ginseng C.A. Meyer improve feeding behavior following radiation-induced pica in rats. Fitoterapia. 2012;83(6):1144-50.
Kim SG. Managements of chemotherapy induced nausea and vomiting. Korean Journal of Clinical Oncology. 2012;6:23-9.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.